世界の心臓再同期療法除細動器（CRT-D）市場：医療機器パイプライン分析2016...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) Overview 6
3 Products under Development 7
3.1 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Stage of Development 7
3.2 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Segment 8
3.3 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Territory 9
3.4 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Regulatory Path 10
3.5 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Estimated Approval Date 11
3.6 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Ongoing Clinical Trials 12
4 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products under Development by Companies 13
4.1 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) Companies – Pipeline Products by Stage of Development 13
4.2 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) – Pipeline Products by Stage of Development 14
5 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) Companies and Product Overview 15
5.1 Boston Scientific Corporation Company Overview 15
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 John Hopkins University Company Overview 20
5.2.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 LivaNova PLC Company Overview 22
5.3.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Medtronic plc Company Overview 28
5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 Sorin Group Italia S.r.l Company Overview 30
5.5.1 Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 St. Jude Medical, Inc. Company Overview 33
5.6.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.7 TransWorld Med Corporation Company Overview 37
5.7.1 TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
6 Cardiac Resynchronisation Therapy – Defibrillators (CRT-D)- Recent Developments 38
6.1 May 16, 2016: Heart Hospital of Austin First in Texas to Offer MultiPoint Pacing Technology for Heart Failure Patients 38
6.2 May 05, 2016: SonR: 35% Risk Reduction in Heart Failure Hospitalization 38
6.3 May 04, 2016: Overlake Becomes First Hospital in Washington to Offer MultiPoint Pacing Technology for Heart Failure Patients 40
6.4 Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 40
6.5 Apr 26, 2016: Allied 100 Acquires Lifeguard Medical Solutions 42
6.6 Apr 18, 2016: St. Jude Medical Announces Launch And First US Implants Of MultiPoint Pacing Technology 42
6.7 Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment 43
6.8 Apr 08, 2016: Lankenau Heart Institute at Paoli Hospital has Implanted the Region’s First MRI-Safe Cardiac Resynchronization Defibrillator 44
6.9 Apr 05, 2016: St. Jude Medical Announces MHLW Approval for MRI Conditional Labeling on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients 44
6.10 Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors 45
6.11 Feb 22, 2016: Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans 46
6.12 Feb 05, 2016: Medtronic’s Amplia MRI Quad CRT-D SureScan System Receives FDA Approval for Treatment of Heart Failure 47
6.13 Feb 05, 2016: Medtronic’s Compia MRI Quad CRT-D SureScan System Receives FDA Approval For Treatment Of Heart Failure 48
6.14 Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 49
6.15 Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification 50
6.16 Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence 50
6.17 Dec 10, 2015: BIOTRONIK Announces Start of New Study Evaluating whether Pacemakers with Closed Loop Stimulation Prevent Reflex Syncope 51
6.18 Dec 02, 2015: St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients 51
6.19 Dec 01, 2015: BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients 52
6.20 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 53
6.21 Aug 25, 2015: BIOTRONIK presents its CRT-Ds Approved for Full-Body MRI Scanning at ESC Congress 2015 54
6.22 Aug 24, 2015: Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems 54
6.23 Aug 05, 2015: BIOTRONIK Announces Start of First Study to Assess Relevance of Defibrillator Back-Up after CRT-D Replacement 55
6.24 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 56
6.25 Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 57
6.26 Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators 58
6.27 Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015 58
6.28 Jul 16, 2015: ZOLL Announces Release of Its CPR Extract Capability 59
6.29 Jul 02, 2015: BIOTRONIK Announces Start of Pioneering BIOWOMEN Study 60
6.30 Jun 22, 2015: Boston Scientific Begins EMBLEM Defibrillator Study In Sudden Cardiac Death 60
6.31 Jun 16, 2015: Hill-Rom Acquires Welch Allyn for USD2.05 Billion 61
7 Appendix 62
7.1 Methodology 62
7.2 About GlobalData 64
7.3 Contact Us 65
7.4 Disclaimer 65